Search results for "Vaccination"


 
Results 81 - 90 of about 515 for "Vaccination".
Sort by: Relevance | Newest | Oldest

Third shot for immunocompromised patients, ACP and others urge vaccine in pregnancy, more COVID-19 news

The FDA and multiple new studies supported a third vaccine dose for organ transplant patients, an ACP statement and an observational trial highlighted benefits of vaccination during pregnancy, and a randomized trial found benefit from budesonide in high-risk outpatients with COVID-19.
https://immattersacp.org/weekly/archives/2021/08/17/1.htm
17 Aug 2021

Interim data find vaccine 66% to 85% effective against symptomatic RSV in older adults

The results from a large ongoing phase 3 trial show success in protection from respiratory syncytial virus (RSV)-associated lower respiratory tract illness on two important primary endpoints, although reductions in hospitalization and death have yet to be shown.
https://immattersacp.org/weekly/archives/2023/04/11/1.htm
11 Apr 2023

HPV vaccination now impacts practice later

This issue covers such topics as HPV vaccination, news from ObesityWeek, and a preview of upcoming events at Internal Medicine Meeting 2017.
https://immattersacp.org/archives/2017/02/editors.htm
1 Feb 2017

Mixed findings on remdesivir for COVID-19, news on SARS-CoV-2 vaccines

Among other news this week, the NIH and the WHO released results from remdesivir trials, more negative findings were published for hydroxychloroquine, and ACP and Annals of Internal Medicine held a vaccine forum featuring Anthony S. Fauci, MD, MACP, and other experts.
https://immattersacp.org/weekly/archives/2020/10/20/2.htm
20 Oct 2020

HPV vaccine efficacy increases, but use lags

Human papillomavirus immunization rates continue, for several reasons, to lag behind those of other vaccines. Experts are formulating new approaches for physicians and patients to ensure that HPV protection is as robust as possible.
https://immattersacp.org/archives/2016/02/HPV.htm
1 Feb 2016

New authorization, guidance on vaccines against SARS-CoV-2

The Moderna COVID-19 vaccine was authorized by the FDA and recommended by the CDC, additional guidance was issued on the use of the Pfizer-BioNTech vaccine, and ACP and Annals of Internal Medicine held a forum on encouraging vaccine uptake.
https://immattersacp.org/weekly/archives/2020/12/22/1.htm
22 Dec 2020

MKSAP Quiz: Evaluation for multiple myeloma

A 64-year-old man is evaluated following a recent diagnosis of multiple myeloma. Chemotherapy is planned to begin in 14 days. Which prophylactic therapy is indicated today?
https://immattersacp.org/weekly/archives/2023/12/05/3.htm
5 Dec 2023

Progress and limitations on vaccines, strokes and readmissions in COVID-19

A report warned that a few health care workers developed COVID-19 shortly after vaccination, and studies showed that strokes were rare in COVID-19 patients but readmissions could not be predicted easily.
https://immattersacp.org/weekly/archives/2021/02/09/1.htm
9 Feb 2021

Pandemic enters new phase with end of PHE

COVID-19 isn't gone, but the end of the U.S. public health emergency does mark some significant changes.
https://immattersacp.org/archives/2023/06/pandemic-enters-new-phase-with-end-of-phe.htm
1 Jun 2023

New vaccine authorization and data, NIH on antibody treatment and ‘long COVID’

The Johnson & Johnson COVID-19 vaccine got an emergency use authorization, and an Israeli study provided more data on the Pfizer vaccine. The NIH recommended an antibody combo for outpatients and named long-term symptoms as post-acute sequelae of SARS-CoV-2 (PASC).
https://immattersacp.org/weekly/archives/2021/03/02/1.htm
2 Mar 2021

Result Page: Prev   4   5   6   7   8   9   10   11   12   13   Next